CD274 and neoplasm: Both in vitro and in vivo experiments have demonstrated that the inhibition of CD73 and adenosine receptors can effectively block the tumor progression and has a good enhancement effect on the efficacy of other drugs such as anti-PD-1/PD-L1 antibodies.